Key result
Intravertebral infusion of angiotensin II at doses as low as 5 ng/kg/min inhibited basal vagal tone compared to intravenous or intracarotid infusion in anesthetized dogs.
Why the study?
Does intravertebral angiotensin II inhibit cardiac vagal efferent activity in anesthetized dogs?
Does intravertebral angiotensin II inhibit cardiac vagal efferent activity in anesthetized dogs?
Angiotensin II can act centrally via the vertebral circulation to inhibit cardiac vagal efferent activity, contributing to its hypertensive effects.
Answers are grounded in this paper and cite their sources.
Central angiotensin II inhibits vagal tone in dogs; leaves open its role in human autonomic regulation.
The effect of intravertebral infusion of angiotensin II on cardiac vagal efferent activity was studied in anesthetized mongrel dogs. Unilateral infusion of doses of angiotensin II as low as 5 ng/kg/min inhibited basal vagal tone and also decreased the slope of the relationship between cardiac vagal efferent activity and systolic blood pressure. Intravenous and intracarotid infusion of similar doses of angiotensin II produced little or no inhibition of vagal tone. These results demonstrate directly that angiotensin II can act centrally to inhibit cardiac vagal efferent activity and provide additional evidence that the increase in blood pressure produced by intravertebral angiotensin II results, at least in part, from decreased vagal tone to the heart.
No takes yet. Share an insight, caveat, or question.
Potter et al. (2008) studied this question. Intravertebral infusion of angiotensin II vs. Intravenous and intracarotid infusion of angiotensin II was evaluated on Cardiac vagal efferent activity and basal vagal tone. Intravertebral infusion of angiotensin II at doses as low as 5 ng/kg/min inhibited basal vagal tone compared to intravenous or intracarotid infusion in anesthetized dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: